Loading...
Market
Story
Tempus AI Prices IPO at $37 per Share, Raises $410.7 Million from 11.1 Million Shares, Valued at $6.1 Billion
Jun 13, 2024, 11:25 PM
Tempus AI, Inc., a precision medicine company that uses AI to process medical data, has successfully priced its initial public offering (IPO) at $37 per share, the top of its marketed range. The company raised $410.7 million through the sale of 11.1 million shares, a full size deal. This pricing reflects a 38% cut from its valuation peak, a challenging outcome for early investors like Google who bought in at higher valuations. The IPO gives Tempus AI a market value of $6.1 billion. The shares are set to debut on Friday.
View original story
Similar markets
AI-powered diagnostics • 33%
Precision medicine • 33%
Data analytics services • 34%
Above $50 • 25%
$40-$50 • 25%
$30-$40 • 25%
Below $30 • 25%
New product launch • 33%
Acquisition of a company • 33%
Major investment in R&D • 33%
Below $40 • 25%
$40 - $50 • 25%
$50 - $60 • 25%
Above $60 • 25%
Above $10 billion • 25%
$7 billion - $10 billion • 25%
$5 billion - $7 billion • 25%
Below $5 billion • 25%
Below $5 billion • 25%
$5 - $7.5 billion • 25%
$7.5 - $10 billion • 25%
Above $10 billion • 25%